Businesstoday
HOME
ECONOMY
IMF sees Indian economy growing 11.5% in 2021
Cairn threatens to seize Indian assets overseas to collect $1.4 billion arbitration award
Indian economy to contract 8% in FY21, growth seen at 9.6% in FY22: FICCI
Tourism Minister Prahlad Patel criticises farmers' action at Red Fort
Amarinder Singh requests PM Modi to agree to farmers' demand
CORPORATE
GAIL to come out with InvITs for two pipelines ahead of company's split
Grofers looks at achieving Rs 10,000 crore in GMV by March 2021
Amazon moves Delhi HC, seeks Biyani's detention, attachment of assets
JSW Steel to kick start production at new Dolvi, Vijayanagar plants in H1 2022
L&T Q3 net profit up 5% at Rs 2,467 crore, order book at record high
MARKETS
Tourism Minister Prahlad Patel criticises farmers' action at Red Fort
Blackstone-backed Aadhar Housing Finance files papers for $1 billion IPO
Indigo Paints IPO: Here's how to check allotment status
Global crude oil prices remain stable on US COVID-19 stimulus apprehensions
Financial markets closed today on account of Republic Day
MONEY
Budget 2021: Expect 'wild card entry' on NRI residential status
Irdai to have panel for separate payments of vehicles, insurance premium
Harassment in fintech loan recovery: Why onus is on borrowers too
IRDAI asks insurers to adopt one aspirational district each
SBI Retirement Benefit Fund launch today; offers free term cover with SIPs
INDUSTRY
Pre-produced Covishield, Covaxin in 6-month race against expiry
Pfizer to seek regulatory approval if India places order for COVID-19 vaccine
ADB lists 10-year masala bonds worth Rs 300 crore on India INX
Green Tax approved for old vehicles; to cost up to 50% of road tax
NSO employment outlook shows jobs are returning, albeit slowly
TECH
FAU-G, Made-in-India war game, records 2 million downloads in 3 hours
Sony Xperia Compact 2021 will be back in 2021: Leaks, Rumours, Specifications, Renders, pricing and everything we know so far
Xiaomi Redmi Note 10 is coming soon: Possible specs, leaks, rumours, India pricing and more
Flipkart Mobiles Bonanza sale isn't just about smartphones, check these offers and deals on cameras
After containment zones, Google Maps will now show when and where to get COVID-19 vaccine
OPINION
Budget 2021: Measures FM Nirmala Sitharaman should announce to spur pandemic-hit economy
Budget 2021: 7 ways to raise funds for big infra spend
Rebooting Economy 61: All that's wrong with guaranteed MSP outside APMC
Budget 2021: Balance between fiscal prudence and growth will be key
How REC trading pause will impact India's green energy aspirations
photos
Budget 2021: Stocks that rose 845% since the last budget
Virtual WEF 2021: What does the meet aim to achieve this year?
How badly did COVID-19 impact air traffic in FY21?
Domestic crude oil prod falls 5.7% in 9M-FY21
Day 2 of BT MindRush 2021: Who said what
Videos
02:55
MHA suspends internet in parts of NCR, calls for meet
01:41
Farmer dies as tractor overturns, protesters claim police fired at him
02:45
India bans TikTok permanently; Green tax approved for old vehicles
04:27
Budget 2021: Key expectations from FM for direct taxes
11:53
Rich should be taxed more to fill the income gap: Abhijit Banerjee
MAGAZINE
February 7, 2021
January 24, 2021
January 10, 2021
December 27, 2020
December 13, 2020
Settings
Logout
BT SPECIALS
SPECIAL ISSUES
SPECIAL REPORTS
BT BUZZ
SLOWDOWN BLUES
JOBS REALITY CHECK
UNION BUDGET
WORLD ECONOMIC FORUM
LOK SABHA ELECTION 2019
REBRAIN OR ROT
EVENTS
MAGAZINE ARCHIVES
BUSINESS TODAY
MONEY TODAY
GADGETS AND GIZMOS
Home
Search
Total 174 results found. Search for
[ CDSCO ]
Results 1 to 21 of 174
Pfizer to seek regulatory approval if India places order for COVID-19 vaccine
Reuters
January 25, 2021
India's Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company's application was made in early December
SEC approves Phase 1 trial of Bharat Biotech's COVID-19 nasal vaccine
BusinessToday.In
January 19, 2021
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Tuesday recommended Bharat Biotech's intranasal vaccine for conducting phase 1 clinical trials for the coronavirus
Manufacturers to be liable if anyone falls sick due to Covid vaccine shot
BusinessToday.In
January 14, 2021
Company shall be liable for all adversities as per CDSCO/Drugs and Cosmetics Act/DCGI policy/approval, says government's purchase order with vaccine makers
COVID-19 vaccine: Pfizer cites short notices, different time zones for approval delay
BusinessToday.In
January 11, 2021
Pfizer is yet to submit additional data sought by India authorities regarding its COVID-19 vaccine for granting emergency use approval to it; the company has missed last three SEC meetings too
Covaxin trial volunteer died of suspected poisoning, clarifies Bharat Biotech
BusinessToday.In
January 9, 2021
Bharat Biotech revealed that one of the participants for Phase III trials passed away on December 21, 2020, and the death was reported to the People's College of Medical Sciences and Research Centre by the son of the deceased
Aviation ministry meets airlines to discuss coronavirus vaccine transportation, delivery
BusinessToday.In
January 7, 2021
COVID-19 vaccination drive: This development comes after the government said that the vaccine would be rolled out 10 days after the date of approval for emergency use
COVID-19 vaccine: Speedy distribution big challenge for govts, says WHO
PTI
January 5, 2021
This daunting challenge is not only for India but also for all the governments across the globe as they start inoculating their populations to tackle the pandemic, noted Dr Soumya Swaminathan, Chief Scientist of WHO
Bharat Biotech's coronavirus vaccine: All you need to know about Covaxin
BusinessToday.In
January 4, 2021
Bharat Biotech's Chairman and Managing Director Dr. Krishna Ella, in a press conference on Monday, January 5, clarified that its vaccine is safe and the company is conducting trials in over 12 countries besides India
Cadila Healthcare share rises 3% on DCGI nod to Phase III trial of COVID-19 vaccine
BusinessToday.In
January 4, 2021
Cadila Healthcare share touched an intraday high of Rs 492.95, rising 3.02% against previous close of Rs 478.50 on BSE
COVID-19 vaccine: Zydus Cadila gets DCGI nod to start phase-3 trials
BusinessToday.In
January 4, 2021
The phase-2 trials of Zydus Cadila's coronavirus vaccine had been conducted in around 1,000 healthy adults
Covaxin may be more effective against UK strain: ICMR chief
BusinessToday.In
January 3, 2021
The ICMR head emphasised that the scientists at ICMR have been successfully able to culture the UK strain and the efficacy of Covaxin against it will be further tested in days to come
'Congratulations India!', PM Modi lauds approval of Serum Institute, Bharat Biotech's COVID-19 vaccines
BusinessToday.In
January 3, 2021
PM Modi thanked doctors, medical staff, police personnel, sanitation workers and all corona warriors for their hard work during the coronavirus outbreak
'All risks paid off; will roll out COVID-19 vaccine in coming weeks,' says Serum CEO Adar Poonawalla
BusinessToday.In
January 3, 2021
COVID-19 vaccine in India: It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, said PM Modi
India approves Serum-Oxford, Bharat Biotech COVID vaccines for emergency use
BusinessToday.In
January 3, 2021
COVID-19 vaccines in India: Oxford-AstraZeneca's coronavirus vaccine Covishield and Bharat Biotech's COVID vaccine Covaxin will be India's first vaccines
COVID-19 vaccine: Bharat Biotech recruits 23,000 subjects, on track for 26,000 volunteers for Phase 3
BusinessToday.In
January 3, 2021
Coronavirus vaccine trials: Bharat Biotech said that it is steadily moving towards its goal of 26,000 volunteers. Phase 3 of human clinical trials for Covaxin began in mid-November
Bharat Biotech's Covaxin gets SEC approval for emergency use
BusinessToday.In
January 2, 2021
The SEC has recommended Covaxin for emergency use authorisation; the recommendation, along with rollout modalities, will now be taken up by the DCGI for a final decision on the matter
Oxford-AstraZeneca vaccine Covishield may get emergency use approval today
BusinessToday.In
January 2, 2021
Covishield DCGI approval: Pune-based Serum Institute will have to provide safety, efficacy and immunogenicity data from the ongoing clinical trials in India and globally
'Govt to cover vaccination cost of 30 crore priority people': COVID-19 task force head
BusinessToday.In
January 2, 2021
Coronavirus vaccination drive: The task force has added 31 COVID-19 vaccine hubs that will supply vaccines to 29,000 vaccination points
Panel seeks more data from Covaxin trials; conditional nod to Oxford's Covishield
BusinessToday.In
January 1, 2021
Covishield has become the first coronavirus vaccine to receive a regulatory nod in India. Now, Drug Controller General of India (DCGI) will take a final call on rolling out the inoculation
Serum-Oxford's 'Covishield' vaccine gets panel nod for emergency use; DCGI next
BusinessToday.In
January 1, 2021
CDSCO's expert panel has recommended the Serum Institute of India's Covishield COVID-19 vaccine for emergency use authorisation to DCGI
PAGES 1 OF 9
1
2
3
4
5
Advertisement
LATEST
Must Read
TECH NEWS
GAIL to come out with InvITs for two pipelines ahead of company's split
Pre-produced Covishield, Covaxin in 6-month race against expiry
FAU-G, Made-in-India war game, records 2 million downloads in 3 hours
IMF sees Indian economy growing 11.5% in 2021
Govt may relax FDI rules for construction, animation, other sectors
More
Reliance Jio Prime vs Airtel, Vodafone, Idea 4G offers
Reliance Jio plans to bring 5G internet to your smartphones
Maruti Suzuki opens online booking for Baleno RS
India Inc to get 9.5 per cent salary hike this year
Five tips to get a good salary hike this year
FAU-G, Made-in-India war game, records 2 million downloads in 3 hours
Sony Xperia Compact 2021 will be back in 2021: Leaks, Rumours, Specifications, Renders, pricing and everything we know so far
Xiaomi Redmi Note 10 is coming soon: Possible specs, leaks, rumours, India pricing and more
Flipkart Mobiles Bonanza sale isn't just about smartphones, check these offers and deals on cameras
After containment zones, Google Maps will now show when and where to get COVID-19 vaccine
More